340B Drug Pricing Reform: Lower Costs for Patients and Hospital Transparency
This bill reforms the 340B drug pricing program to ensure that discounts directly benefit low-income and uninsured patients through capped out-of-pocket costs. It also mandates stricter reporting requirements for hospitals to prove they are using savings to support charity care and vulnerable communities.
Key points
Low-income patients will pay capped amounts ($0, $35, or $50) for prescription drugs at participating facilities based on their income.
Hospitals are required to publicly report how they use the savings from drug discounts to fund charity care.
Insurers are prohibited from discriminating against pharmacies or patients participating in the 340B program through lower reimbursement or restrictive terms.
Introduced
Citizen Poll